Click for best price
ChemotherapyInduced Nausea Vomiting CINV Market Size, Share 2022
Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides chemotherapy, there are various types of factors that puts a patient high risk for CINV including female sex, history of alcohol use, CINV & motion sickness and anxiety or depression.
This report contains market size and forecasts of Chemotherapy-Induced Nausea and Vomiting (CINV) in Global, including the following market information:
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chemotherapy-Induced Nausea and Vomiting (CINV) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CINV Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chemotherapy-Induced Nausea and Vomiting (CINV) include Merck, Eisai, ProStrakan, Helsinn Holding, Mundipharma, Qilu Pharma, Teva, Novartis and Heron Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chemotherapy-Induced Nausea and Vomiting (CINV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segment Percentages, by Type, 2021 (%)
CINV
PONV
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chemotherapy-Induced Nausea and Vomiting (CINV) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chemotherapy-Induced Nausea and Vomiting (CINV) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Eisai
ProStrakan
Helsinn Holding
Mundipharma
Qilu Pharma
Teva
Novartis
Heron Therapeutics
Roche
Mylan
Tesaro
| Report Attributes |
Report Details |
| Report Title |
Chemotherapy-Induced Nausea and Vomiting (CINV) Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Overall Market Size
2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size: 2021 VS 2028
2.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players in Global Market
3.2 Top Global Chemotherapy-Induced Nausea and Vomiting (CINV) Companies Ranked by Revenue
3.3 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Companies
3.4 Top 3 and Top 5 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Chemotherapy-Induced Nausea and Vomiting (CINV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting (CINV) Players in Global Market
3.6.1 List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Markets, 2021 & 2028
4.1.2 CINV
4.1.3 PONV
4.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue & Forecasts
4.2.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2017-2022
4.2.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2023-2028
4.2.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Diagnostic Centers
5.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue & Forecasts
5.2.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2017-2022
5.2.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2023-2028
5.2.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2021 & 2028
6.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue & Forecasts
6.2.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2017-2022
6.2.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2023-2028
6.2.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2017-2028
6.3.2 US Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.3.3 Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.3.4 Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2017-2028
6.4.2 Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.4.3 France Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.4.4 U.K. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.4.5 Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.4.6 Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.4.7 Nordic Countries Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.4.8 Benelux Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2017-2028
6.5.2 China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.5.3 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.5.4 South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.5.5 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.5.6 India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2017-2028
6.6.2 Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.6.3 Argentina Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2017-2028
6.7.2 Turkey Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.7.3 Israel Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.7.4 Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
6.7.5 UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, 2017-2028
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.1.4 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2017-2022)
7.1.5 Merck Key News
7.2 Eisai
7.2.1 Eisai Corporate Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.2.4 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2017-2022)
7.2.5 Eisai Key News
7.3 ProStrakan
7.3.1 ProStrakan Corporate Summary
7.3.2 ProStrakan Business Overview
7.3.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.3.4 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2017-2022)
7.3.5 ProStrakan Key News
7.4 Helsinn Holding
7.4.1 Helsinn Holding Corporate Summary
7.4.2 Helsinn Holding Business Overview
7.4.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.4.4 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2017-2022)
7.4.5 Helsinn Holding Key News
7.5 Mundipharma
7.5.1 Mundipharma Corporate Summary
7.5.2 Mundipharma Business Overview
7.5.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.5.4 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2017-2022)
7.5.5 Mundipharma Key News
7.6 Qilu Pharma
7.6.1 Qilu Pharma Corporate Summary
7.6.2 Qilu Pharma Business Overview
7.6.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.6.4 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2017-2022)
7.6.5 Qilu Pharma Key News
7.7 Teva
7.7.1 Teva Corporate Summary
7.7.2 Teva Business Overview
7.7.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.7.4 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2017-2022)
7.7.5 Teva Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.8.4 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2017-2022)
7.8.5 Novartis Key News
7.9 Heron Therapeutics
7.9.1 Heron Therapeutics Corporate Summary
7.9.2 Heron Therapeutics Business Overview
7.9.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.9.4 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2017-2022)
7.9.5 Heron Therapeutics Key News
7.10 Roche
7.10.1 Roche Corporate Summary
7.10.2 Roche Business Overview
7.10.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.10.4 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2017-2022)
7.10.5 Roche Key News
7.11 Mylan
7.11.1 Mylan Corporate Summary
7.11.2 Mylan Business Overview
7.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.11.4 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2017-2022)
7.11.5 Mylan Key News
7.12 Tesaro
7.12.1 Tesaro Corporate Summary
7.12.2 Tesaro Business Overview
7.12.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Major Product Offerings
7.12.4 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global Market (2017-2022)
7.12.5 Tesaro Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Opportunities & Trends in Global Market
Table 2. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers in Global Market
Table 3. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Restraints in Global Market
Table 4. Key Players of Chemotherapy-Induced Nausea and Vomiting (CINV) in Global Market
Table 5. Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Chemotherapy-Induced Nausea and Vomiting (CINV) Product Type
Table 9. List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting (CINV) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 32. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), (2017-2022)
Table 33. Eisai Corporate Summary
Table 34. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 35. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), (2017-2022)
Table 36. ProStrakan Corporate Summary
Table 37. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 38. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), (2017-2022)
Table 39. Helsinn Holding Corporate Summary
Table 40. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 41. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), (2017-2022)
Table 42. Mundipharma Corporate Summary
Table 43. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 44. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), (2017-2022)
Table 45. Qilu Pharma Corporate Summary
Table 46. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 47. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), (2017-2022)
Table 48. Teva Corporate Summary
Table 49. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 50. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 53. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), (2017-2022)
Table 54. Heron Therapeutics Corporate Summary
Table 55. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 56. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), (2017-2022)
Table 57. Roche Corporate Summary
Table 58. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 59. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), (2017-2022)
Table 60. Mylan Corporate Summary
Table 61. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 62. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), (2017-2022)
Table 63. Tesaro Corporate Summary
Table 64. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Product Offerings
Table 65. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Chemotherapy-Induced Nausea and Vomiting (CINV) Segment by Type in 2021
Figure 2. Chemotherapy-Induced Nausea and Vomiting (CINV) Segment by Application in 2021
Figure 3. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2021
Figure 8. By Type - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2017-2028
Figure 12. US Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2017-2028
Figure 16. Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 17. France Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2017-2028
Figure 24. China Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 28. India Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2017-2028
Figure 30. Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share, 2017-2028
Figure 33. Turkey Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
